What’s New and What’s Next in CLL

About this episode

Dr. Brad Kahl provides an overview of chronic lymphocytic leukemia, discussing diagnostics, treatment options, and future developments in the field.

Brad Kahl, MD, Siteman Cancer Center, St. Louis MO Recorded on January 27, 2026 Brad Kahl, MD Professor of Medicine Division of Oncology, Department of Medicine Washington University School of Medicine Director, Lymphoma Program Siteman Cancer Center St. Louis, MO In this episode, join Dr. Brad Kahl, Director of the Lymphoma Program at the Siteman Cancer Center in St. Louis, Missouri, as he delivers a concise and practical overview of chronic lymphocytic leukemia (CLL), from initial disease presentation to key diagnostic considerations. Dr. Kahl discusses the prognostic value of cytogenetic testing and its impact on treatment selection and reviews currently approved therapeutic options alongside notable updates from the latest American Society of Hematology (ASH) meeting. He also examines emerging agents and ongoing clinical trials that are shaping the future CLL treatment landscape. The conversation further explores strategies for managing side effects, addressing complications, and supporting patients and caregivers. Tune in for this timely and informative discussion! Additional Blood Cancer United Resources: Blood Cancer United Accredited and Non-Accredited Healthcare…

People in this episode

Guest: Brad Kahl Md

Topics covered

• chronic lymphocytic leukemia
• diagnostic considerations
• cytogenetic testing
• treatment options
• clinical trials

Keywords

• CLL
• hematology
• oncology
• therapeutics
• ASH meeting

Mentioned in this episode

Places: St. Louis MO, St. Louis, Missouri

More episodes of Treating Blood Cancers

• Optimizing HSCT in Blood Cancers · June 2, 2026 · 39 min
• Clinical Strategies for Supporting Couples, Care Partners, and Families in Oncology Care · May 8, 2026 · 35 min
• Driving Progress in AML · April 23, 2026 · 34 min
• Redefining Normal: Clinical Insights for Healthcare Professionals Supporting Survivors After Treatment · April 13, 2026 · 34 min
• Optimizing Outcomes in Myeloma · March 24, 2026 · 40 min
• Strategies to Navigate Expanded Access (Compassionate Use) in Treating Pediatric Oncology · March 3, 2026 · 40 min